Literature DB >> 20174906

[Motivation of patients to participate in clinical trials. An explorative survey].

Charly Gaul1, Annett Malcherczyk, Thomas Schmidt, Jürgen Helm, Johannes Haerting.   

Abstract

BACKGROUND: Difficulties in recruiting patients for clinical trials lead to increasing costs, and prolonged implementation of evidences into medical practice. Knowledge about motivation and barriers in potential participants would be helpful to develop successful recruitment strategies. Currently, no systematic research of determining factors affecting the decision to participate in clinical studies is available from German samples.
METHODS: After been given details about a potential participation in a clinical or diagnostic study in nine study centers, patients were recruited for an additional structured questionnaire survey concerning motivation and barriers to participation.
RESULTS: 62 patients were included into the survey. 95.1% did not have any experience with clinical studies before. 66.1% met the physician explaining the study and asking for informed consent for the first time. Despite this, 96.6% judged the physician to be competent. Family and friends were important for decision-making about the participation in a study. Gender was only of marginal influence. The majority of patients (91.4%) expected advantages of the study for their own. 88% of the patients denominated potential advantages for other patients as an additional motivator. The possibility of adverse events was inferior for patients in decision-making about participation in a clinical trial.
CONCLUSION: Physicians recruiting patients for clinical studies should be well prepared about details of the study and should have adequate time for an introductory conversation in a quiet environment. Including relatives into the introductory conversation may enhance the motivation and therefore the success of recruitment. Potential advantages of a participation for the own treatment and additionally for other patients should be highlighted. Possible side effects should be explained in a realistic manner.

Entities:  

Mesh:

Year:  2010        PMID: 20174906     DOI: 10.1007/s00063-010-1016-4

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  14 in total

Review 1.  Patient recruitment: the costly and growing bottleneck in drug development.

Authors:  Kathleen B Drennan
Journal:  Drug Discov Today       Date:  2002-02-01       Impact factor: 7.851

2.  Expectations and experiences of patients with cancer participating in phase I clinical trials.

Authors:  L H Yoder; T J O'Rourke; A Etnyre; D T Spears; T D Brown
Journal:  Oncol Nurs Forum       Date:  1997-06       Impact factor: 2.172

3.  [The case "Scott Reuben"].

Authors:  E M Pogatzki-Zahn; M Strumpf; R-D Treede
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

4.  Are subjects satisfied with the informed consent process? A survey of research participants.

Authors:  Janet E Pope; David P Tingey; J Malcolm O Arnold; Paul Hong; Janine M Ouimet; Adriana Krizova
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

5.  Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.

Authors:  C K Daugherty
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

6.  Trials and tribulations: understanding motivations for clinical research participation amongst adults with cystic fibrosis.

Authors:  Karen Lowton
Journal:  Soc Sci Med       Date:  2005-10       Impact factor: 4.634

7.  [Motivation and barriers to participation in clinical trials].

Authors:  Charly Gaul; Thomas Schmidt; Jürgen Helm; Heike Hoyer; Johannes Haerting
Journal:  Med Klin (Munich)       Date:  2006-11-15

8.  Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.

Authors:  Scott D Halpern; Jason H T Karlawish; David Casarett; Jesse A Berlin; Raymond R Townsend; David A Asch
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

9.  Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.

Authors:  E Kodish; C Stocking; M J Ratain; A Kohrman; M Siegler
Journal:  J Clin Oncol       Date:  1992-11       Impact factor: 44.544

10.  Perceptions of cancer patients and their physicians involved in phase I trials.

Authors:  C Daugherty; M J Ratain; E Grochowski; C Stocking; E Kodish; R Mick; M Siegler
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

View more
  3 in total

1.  Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine.

Authors:  Jutta Bleidorn; Sermin Bucak; Ildikó Gágyor; Eva Hummers-Pradier; Marie-Luise Dierks
Journal:  Ger Med Sci       Date:  2015-10-14

2.  Barriers and Facilitating Factors for Research Involvement in Cancer Centers: A Survey of Colorectal Cancer Center Coordinators in Germany, Austria, and Switzerland.

Authors:  Christoph Kowalski; Stefan Post; Thomas Seufferlein; Stefan R Benz; Julia Ferencz; Simone Wesselmann
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

3.  A prospective community engagement initiative to improve clinical research participation in patients with peripheral artery disease.

Authors:  Kate Levenberg; David N Proctor; Stephan R Maman; J Carter Luck; Amanda J Miller; Faisal Aziz; John F Radtka; Matthew D Muller
Journal:  SAGE Open Med       Date:  2020-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.